The risk of non-AIDS defining events is lower in ART-naive HIV controllers than in normal progressors on suppressive ART.

Albert L GroenendijkPedro Miranda AfonsoFerdinand WitMartinus J T BlaauwLouise E van EekerenTwan OttenWilhelm A J W VosNadira VadaqJéssica C Dos SantosJan van LunzenAndre van der VenCasper RokxAnnelies Verbon

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

We found a lower risk of nADE in HIV controllers than NP-ART, especially in those with low plasma viral loads. Initiation of ART did not alter the nADE risk in HIV controllers. Our findings help clinicians to decide on prescribing ART in HIV controllers.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
hiv testing
hepatitis c virus
primary care
palliative care